600 resultados para Enzima conversora da angiotensina
Resumo:
Este experimento foi realizado para avaliar os efeitos da suplementação de enzimas exógenas (pancreatina suína) em microdietas sobre o crescimento, a sobrevivência e as alterações morfológicas do trato digestório de larvas de pacu, Piaractus mesopotamicus. Foram testados oito programas alimentares: alimentação exclusiva com náuplios de Artemia (AV); alimentação exclusiva com dieta microparticulada com (DMP) ou sem (DM) suplementação enzimática; substituição, aos cinco dias, dos náuplios de Artemia por dietas inertes com (AV5DMP) ou sem (AV5DM) suplementação; e substituição dos náuplios aos dez dias por dietas com (AV10DMP) ou sem (AV10DM) suplementação. O experimento teve duração de 28 dias. Larvas que receberam o alimento vivo durante todo o período experimental apresentaram maiores médias de peso. O efeito negativo da supressão do alimento vivo sobre o crescimento das larvas foi verificado tanto na substituição aos cinco dias como aos dez dias. No entanto, nas avaliações biométricas subseqüentes, observaram-se efeitos positivos da suplementação enzimática; a partir do 20º dia de experimento, as larvas que receberam a dieta suplementada com enzima exógena apresentaram peso médio estatisticamente superior ao daquelas alimentadas com a dieta sem suplementação. As diferenças morfológicas mais evidentes proporcionadas pela suplementação enzimática foram observadas nas larvas que receberam substituição alimentar aos cinco dias. As diferenças foram relativas à quantidade de grânulos de zimogênio no pâncreas e às inclusões supranucleares no intestino. As larvas submetidas à transição alimentar aos dez dias de experimento já apresentavam diferenciação morfológica do sistema digestório mais avançada, assemelhando-se muito às larvas do tratamento com alimento vivo. Os resultados deste experimento indicam que a suplementação com pancreatina proporcionou efeitos positivos sobre o crescimento e a sobrevivência das larvas de pacu.
Resumo:
Anti-inflammatory drugs are known to be the most widely-marketed drugs in the world, despite their serious side effects, mainly on the gastrointestinal tract. Thus, there are constant efforts to discover new prototypes with improved therapeutic activity and safety for the patient. Since the advent of the computational chemistry, the theoretical study of the physiological behavior of a new compound and hence an understanding of its supposed mechanism of action have been made a lot more accessible. Thus, molecule-receptor mathematical modeling was applied to compound I (1-(2,6-dichlorophenyl)indolin-2-one), to predict theoretically its ability to inhibit, selectively, the COX-2 isoform of prostaglandin endoperoxide synthase (PGHS-2), and the best positions to introduce chemical groups and to make molecular modifications.
Resumo:
Type-1 diabetes patients suffer from frequent episodes of acidosis caused by an increased fatty acid metabolism and consequently increased plasma level of acetoacetate (AcAc) and β-hydroxybutyrate (β-HOB). This article describes a study of the effects of pathological concentrations of AcAc and β-HOB on lipoperoxidation, cell viability and the release of the CXCL8 (IL-8) cytokine by activated neutrophils. Neutrophils from healthy donors were isolated by density gradient (Histopaque® 1077/1119) and incubated with the ketone bodies. Lipoperoxidation was determined as thiobarbituric acid reactive substances (TBARS). The cell viability was evaluated by the release of intracellular lactate dehydrogenase. The release of CXCL8 was measured by ELISA in a 24-h culture of opsonized zymosan-stimulated neutrophils. AcAc, but not β-HOB, provoked a dose-dependent increase in the neutrophil membrane lipoperoxidation (p<0.05; r =0.9915). In the cytotoxicity assay, a dose-dependent release of LDH was observed when the neutrophils were incubated with AcAc in concentrations up to 40 mM (p<0.05). β-HOB was devoid of effect. The release of CXCL8 was inhibited by AcAc and β-HOB in a dose-dependent manner. In conclusion, these results suggest that the accumulation of ketone bodies in diabetic patients could be involved in their usually increased susceptibility to infection.
Resumo:
A strain of the flamentous fungus Aspergillus niger was isolated and shown to possess extracellular xylanolytic activity. These enzymes have biotechnological potential and can be employed in various industries. This fungus produced its highest xylanase activity in a medium made up of 0.1% CaCO3, 0.5% NaCl, 0.1% NH4Cl, 0.5% corn steep liquor and 1% carbon source, at pH 8.0. A low-cost hemicellulose residue (powdered corncob) proved to be an excellent inducer of the A. niger xylanolytic complex. Filtration of the crude culture medium with suspended kaolin was ideal for to clarify the extract and led to partial purifcation of the xylanolytic activity. The apparent molecular mass of the xylanase was about 32.3 kDa. Maximum enzyme activity occurred at pH 5.0 and 55-60oC. Apparent Km was 10.41 ± 0.282 mg/mL and Vmax was 3.32 ± 0.053 U/mg protein, with birchwood xylan as the substrate. Activation energy was 4.55 kcal/mol and half-life of the crude enzyme at 60oC was 30 minutes. Addition of 2% glucose to the culture medium supplemented with xylan repressed xylanase production, but in the presence of xylose the enzyme production was not affected.
Resumo:
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Resumo:
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
Resumo:
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Resumo:
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Resumo:
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
Resumo:
Pós-graduação em Biofísica Molecular - IBILCE
Resumo:
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
Resumo:
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)